SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma-Reference-Cited by-同舟云学术

SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma

Published:2016-05-19 Issue:26 Volume:7 Page:39970-39979
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Huang Jun¹²,Fan Xing-Xing³,He Jiaxi¹,Pan Hui¹,Li Run-Ze³,Huang Liyan¹,Jiang Zebo³,Yao Xiao-Jun³,Liu Liang³,Lai-Han Leung Elaine³,He Jian-Xing¹²

Affiliation:

1. State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease, The 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

2. Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

3. State Key Laboratory of Quality Research in Chinese Medicine/Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau (SAR), China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells;Journal of Ovarian Research;2024-04-02

2. Targeting dysregulated lipid metabolism in the tumor microenvironment;Archives of Pharmacal Research;2023-12

3. Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas;International Journal of Molecular Sciences;2023-09-21

4. Unveiling the MUFA–Cancer Connection: Insights from Endogenous and Exogenous Perspectives;International Journal of Molecular Sciences;2023-06-08

5. Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2;European Journal of Pharmacology;2023-06